Ghost Tree Capital as of Sept. 30, 2018
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 51 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 10.2 | $48M | 500k | 95.87 | |
| Mirati Therapeutics | 7.4 | $35M | 735k | 47.10 | |
| Sarepta Therapeutics (SRPT) | 7.2 | $34M | 210k | 161.51 | |
| Ptc Therapeutics I (PTCT) | 5.0 | $24M | 500k | 47.00 | |
| ACADIA Pharmaceuticals (ACAD) | 4.4 | $21M | 1.0M | 20.76 | |
| Alnylam Pharmaceuticals (ALNY) | 4.2 | $20M | 225k | 87.52 | |
| Endocyte | 4.2 | $20M | 1.1M | 17.76 | |
| Immunomedics | 3.9 | $18M | 884k | 20.83 | |
| Tesaro | 3.7 | $18M | 450k | 39.01 | |
| Dicerna Pharmaceuticals | 3.6 | $17M | 1.1M | 15.26 | |
| Ascendis Pharma A S (ASND) | 3.4 | $16M | 225k | 70.86 | |
| Invesco exchange traded (FXF) | 2.6 | $12M | 129k | 95.31 | |
| Assembly Biosciences | 2.6 | $12M | 325k | 37.14 | |
| Bluebird Bio (BLUE) | 2.3 | $11M | 75k | 146.00 | |
| Retrophin | 2.1 | $10M | 350k | 28.73 | |
| Zogenix | 2.1 | $9.9M | 200k | 49.60 | |
| Rocket Pharmaceuticals (RCKT) | 2.1 | $9.8M | 400k | 24.62 | |
| Obseva Sa | 2.0 | $9.6M | 535k | 18.03 | |
| Argenx Se (ARGX) | 2.0 | $9.5M | 125k | 75.84 | |
| Zafgen | 1.9 | $8.8M | 750k | 11.69 | |
| Portola Pharmaceuticals | 1.7 | $8.0M | 300k | 26.63 | |
| Tricida | 1.6 | $7.6M | 250k | 30.55 | |
| Biohaven Pharmaceutical Holding | 1.6 | $7.5M | 200k | 37.55 | |
| Viewray (VRAYQ) | 1.5 | $7.0M | 750k | 9.36 | |
| Kadmon Hldgs | 1.4 | $6.7M | 2.0M | 3.34 | |
| Global Blood Therapeutics In | 1.3 | $6.2M | 162k | 38.00 | |
| Anaptysbio Inc Common (ANAB) | 1.3 | $6.0M | 60k | 99.77 | |
| Glycomimetics (GLYC) | 1.2 | $5.8M | 400k | 14.40 | |
| Kalvista Pharmaceuticals (KALV) | 1.1 | $5.0M | 225k | 22.11 | |
| BioDelivery Sciences International | 0.9 | $4.2M | 1.5M | 2.80 | |
| Kura Oncology (KURA) | 0.9 | $4.0M | 230k | 17.50 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $3.8M | 500k | 7.63 | |
| Urovant Sciences | 0.8 | $3.6M | 300k | 12.00 | |
| Radius Health | 0.8 | $3.6M | 200k | 17.80 | |
| Allakos (ALLK) | 0.7 | $3.4M | 75k | 44.99 | |
| Apellis Pharmaceuticals (APLS) | 0.7 | $3.3M | 185k | 17.78 | |
| Madrigal Pharmaceuticals (MDGL) | 0.7 | $3.0M | 14k | 214.15 | |
| Arvinas Ord (ARVN) | 0.6 | $3.0M | 175k | 16.87 | |
| Genocea Biosciences | 0.6 | $2.7M | 3.5M | 0.78 | |
| Neos Therapeutics | 0.5 | $2.3M | 483k | 4.85 | |
| Catalyst Biosciences | 0.5 | $2.2M | 200k | 10.78 | |
| Flamel Technologies Sa (AVDL) | 0.4 | $2.0M | 450k | 4.39 | |
| Aquinox Pharmaceuticals | 0.3 | $1.5M | 500k | 2.93 | |
| Sage Therapeutics (SAGE) | 0.3 | $1.3M | 9.5k | 141.26 | |
| Fate Therapeutics (FATE) | 0.3 | $1.2M | 75k | 16.29 | |
| Gritstone Oncology Ord (GRTS) | 0.2 | $1.1M | 75k | 14.24 | |
| Spectrum Pharmaceuticals | 0.2 | $793k | 47k | 16.80 | |
| Edge Therapeutics | 0.2 | $820k | 1.0M | 0.82 | |
| Insmed (INSM) | 0.1 | $526k | 26k | 20.23 | |
| Motus Gi Hldgs Incorporated | 0.1 | $510k | 100k | 5.10 | |
| Tg Therapeutics (TGTX) | 0.1 | $255k | 46k | 5.60 |
